Dr. Emmy Dolman

Introducing Dr. Emmy Dolman from the Children’s Cancer Institute, one of our 2025–2026 grant recipients.

Dr. Dolman is a Senior Scientist in the Zero Childhood Cancer (ZERO) Program. She also holds a Conjoint Senior Lecturer position in the Faculty of Medicine at UNSW Sydney.

Dr. Dolman’s research focuses on a protein called Aurora Kinase A (AURKA), which both stabilises MYCN and helps neuroblastoma to evade detection by the immune system.

By using a new type of therapy called PROTACs (PROteolysis TArgeting Chimeras), Dr. Dolman and her team are working to degrade AURKA entirely, thereby disrupting the protein’s role in stabilising MYCN.

This research has the potential to make neuroblastoma more “visible” to the immune system and therefore more sensitive to immunotherapy. If successful, this project could lead to a groundbreaking combination treatment for high-risk neuroblastoma, and improve survival rates and quality of life for children facing this aggressive cancer.

Donate to fund reserach

Neuroblastoma Australia has raised over $4 million for innovative research, funding 17 early stage projectsfocused on changing the future for children with neuroblastoma – one of the most aggressive childhood cancers. Behind every dollar raised are children and families facing the devastating impact of this disease, like the story shared here.

Donate now to help fund potentially life-changing medical research that gives hope to children diagnosed with neuroblastoma. Donations are secure and you’ll receive an immediate tax-deductible receipt. Thank you.